Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

CAR-T therapy outcomes in patients over 70 years old

Retrospective Studies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Guillaume Dachy

Non relapse mortality after CAR-T therapy

Retrospective Studies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Charlotte Graham

CAR T-cell in elderly patients suffering from non-Hodgkin lymphoma or multiple myeloma

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Guillaume Dachy

Non-relapse mortality post CAR-T cell therapy

Retrospective Studies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Charlotte Graham

Long-term outcomes of PTCy vs. ATG in MRD, MUD, MMUD

Études rétrospectives

Toutes les maladies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Hélène Schoemans

CVC and anticoagulation survey in HCT and CAR-T

Toutes les maladies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Severity and response criteria in transplant-associated thrombotic microangiopathy

Retrospective Studies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Treatment and outcome of sHLH after allogeneic hematopoetic stem cell transplantation

Retrospective Studies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Survey on ICU organization and ICU admission after haematopoietic cell transplantation with special emphasis on infectious causes

Closed Survey/Study

Infectious Diseases Working Party (IDWP)

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Joanna Drozd-Sokolowska

Infections following CAR-T therapy. A retrospective collaborative study between the Infectious Diseases Working Party (IDWP), the Cellular Therapy and Immunobiology Working Party (CTIWP), the Transplant Complications Working Party (TCWP) of the EBMT, the European Hematology Association (EHA), and the Medical College of Wisconsin.

Lymphome non hodgkinien (LNH)

Leucémie Aiguë Lymphoblastique (LAL)

GoCART Coalition

Infectious Diseases Working Party (IDWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Autoimmune and autoinflammatory complications after CAR-T cell therapy - a joint study on behalf of the EBMT - ADWP, CTIWP and TCWP

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Myélome multiple (MM) ou autre dyscrasies plasmocytaires (PCD)

Lymphome non hodgkinien (LNH)

GoCART Coalition

Autoimmune Diseases Working Party (ADWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Multicentric evaluation of CAR-T cell induced pseudoprogression prevalence (PrevCARTiPP)

Études rétrospectives

Toutes les maladies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Friedrich Stoelzel